Upcoming Workshops
- May25Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
Register - Jun22Update On Marginal Zone Lymphoma (MZL)
Register
Past Workshops
- Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
- Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
- Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
- Coping with the Stresses of Caregiving When Your Loved One Has Mantle Cell Lymphoma (MCL)
Part II of Living with Mantle Cell Lymphoma (MCL) - Marginal Zone Lymphoma (MZL): Treatment Updates
- What’s New in Diagnostic Technologies for People Living with Blood Cancers
Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer - Update from the 2021 American Society of Hematology (ASH) Annual Meeting
- Update on Marginal Zone Lymphoma (MZL)
- Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
- Update on Diffuse Large B-Cell Lymphoma (DLBCL)
- Update on CAR T-Cell Therapies
- Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
- Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
- Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
- Update on CAR-T Cell Therapy
- Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
- Taking Your Blood Cancer Treatment on Schedule
- Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
- The Emerging Role of Immunotherapy in the Treatment of Lymphoma